Methylene Blue can cycle between oxidised and reduced states, which explains much of its experimental value in redox chemistry, including its documented bioenergetic effects in isolated brain mitochondria (Learn more). Research applications include mitochondrial electron-transfer models, cellular energetics, enzyme assays, histology and biochemical staining, alongside related mitochondrial-research compounds such as MOTS-c and SS-31. Because commercial forms can differ in hydration state and grade, the batch documentation should define the exact material supplied.
Caro’s cotton dye and Ehrlich’s living stain
Methylene Blue started out as a textile colour. Heinrich Caro, head of research at BASF in Ludwigshafen, synthesised it in 1876 while searching for a pure blue that would take to cotton, and in 1877 BASF received Germany’s first patent for a coal-tar dye. It soon crossed into the laboratory. Robert Koch used it in the staining work behind his 1882 description of the tuberculosis bacillus, and in 1886 Paul Ehrlich found that it picked out living nerve fibres while leaving the surrounding tissue pale.
That selectivity planted an idea that shaped modern pharmacology: if a dye can seek out one kind of cell, perhaps a chemical can be made to strike one kind of target. Malaria parasites took up the stain as well, and in 1891 Ehrlich and Paul Guttmann gave methylene blue to two malaria patients in Berlin, a step often described as the first use of a fully synthetic compound as a medicine. Its three-ring phenothiazine skeleton later reappeared across whole twentieth-century drug classes, from early antihistamines to chlorpromazine.
Blue and colourless: the two-state redox cycle
Almost everything useful about Methylene Blue traces back to one reversible reaction. The oxidised, positively charged form is intensely blue, absorbing most strongly in the red near 664 nm. Give it two electrons and a proton and it becomes leucomethylene blue, which is colourless. Oxygen readily pulls those electrons back, restoring the colour and generating superoxide and hydrogen peroxide along the way. Chemistry teachers know this as the “blue bottle” demonstration: glucose in alkaline solution bleaches the dye, and shaking the flask brings the blue straight back as air dissolves in.
Biology exploits the same switch. Living cells and bacteria reduce the dye with their own enzymes, the basis of dye-reduction tests such as the long-established check on raw milk, where faster loss of colour points to a larger microbial load. Concentration matters too. Dilute solutions hold mostly single molecules, but as concentration rises the flat rings stack into dimers that absorb at shorter wavelengths, around 610 nm, so quantitative spectroscopy relies on dilute samples and fixed conditions.
A detour around blocked mitochondrial complexes
Inside mitochondria, Methylene Blue can stand in as an electron carrier. It collects electrons from NADH and hands them straight to cytochrome c, letting electron flow continue on to complex IV and oxygen even when complex I or complex III has been chemically shut down. A 2011 paper in the Journal of Biological Chemistry framed this as alternative mitochondrial electron transfer: in cultured neuronal cells the dye raised oxygen consumption and cut anaerobic glycolysis, while a derivative whose redox centre had been disabled by N-acetylation left complex activities unchanged, tying the effect to the redox cycle itself.
Later work tested the idea more strictly. Experiments on isolated mitochondria from rats, mice and guinea pigs, published in 2021, found Methylene Blue could reduce cytochrome c and improve respiration and membrane potential after complex III was blocked with antimycin or myxothiazol, alongside some unusual respiratory changes. It is far from a single-target probe, though. The dye also inhibits nitric oxide synthase and soluble guanylate cyclase, and its behaviour can reverse at higher concentrations, so concentration-response curves and redox-inactive controls are standard parts of experimental design.
Red light and singlet oxygen in photodynamic research
Strong absorption of red light makes Methylene Blue an effective photosensitiser. After absorbing a photon, the molecule can cross into a long-lived excited triplet state and pass that energy to dissolved oxygen, producing singlet oxygen, a highly reactive species that damages nearby lipids, proteins and nucleic acids. Because the dye binds to and slots between the bases of DNA and RNA, that damage lands exactly where it disrupts viruses and microbes most.
Blood services put this to practical use. Methylene Blue plus visible light is an established pathogen-reduction method for plasma, and commercial systems such as THERAFLEX MB-Plasma illuminate each unit after the dye is added; published laboratory work has shown it reducing Ebola virus and MERS coronavirus in spiked plasma to undetectable levels. Researchers have also explored photodynamic approaches against bacteria, fungi and biofilms in culture and in cancer cell lines, helped by the fact that red light travels further through biological material than blue or green.
